APO Research
Talk to an analyst

APO RESEARCH · REPORT

Betahistine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Betahistine Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchBetahistine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Betahistine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Betahistine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Betahistine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Betahistine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Betahistine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Betahistine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Betahistine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Betahistine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Betahistine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Takeda Pharmaceutical Company Limited, Mylan, Orion Corporation, Nichi-Iko Pharmaceutical, HENNIG ARZNEIMITTEL GmbH & Co. KG, EA Pharma Co., Ltd., DOC Generici and Disphar International B.V., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Betahistine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Betahistine, also provides the sales of main regions and countries. Of the upcoming market potential for Betahistine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Betahistine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Betahistine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Betahistine sales, projected growth trends, production technology, application and end-user industry.

Betahistine Segment by Company

TOWA PHARMACEUTICAL CO., LTD

Takeda Pharmaceutical Company Limited

Mylan

Orion Corporation

Nichi-Iko Pharmaceutical

HENNIG ARZNEIMITTEL GmbH & Co. KG

EA Pharma Co., Ltd.

DOC Generici

Disphar International B.V.

Ciclum Farma Unipessoal

Betahistine Segment by Type

8mg

25mg

Others

Betahistine Segment by Application

Cerebral Thrombosis

Cerebral Embolism

Others

Betahistine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Betahistine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Betahistine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Betahistine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Betahistine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Betahistine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Betahistine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 8mg Major Manufacturers Table 3. 25mg Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Betahistine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cerebral Thrombosis Major Manufacturers Table 7. Cerebral Embolism Major Manufacturers Table 8. Others Major Manufacturers Table 9. Betahistine Industry Trends Table 10. Betahistine Industry Drivers Table 11. Betahistine Industry Opportunities and Challenges Table 12. Betahistine Industry Restraints Table 13. Global Betahistine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Betahistine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Betahistine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Betahistine Revenue Market Share by Region (2021-2026) Table 17. Global Betahistine Revenue Market Share by Region (2027-2032) Table 18. Global Betahistine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Betahistine Sales by Region (2021-2026) & (K Units) Table 20. Global Betahistine Sales by Region (2027-2032) & (K Units) Table 21. Global Betahistine Sales Market Share by Region (2021-2026) Table 22. Global Betahistine Sales Market Share by Region (2027-2032) Table 23. Global Betahistine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Betahistine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Betahistine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Betahistine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Betahistine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Betahistine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Betahistine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Betahistine Manufacturers, Product Type & Application Table 31. Global Betahistine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Betahistine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Betahistine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Betahistine Revenue Market Share by Type (2021-2026) Table 38. Global Betahistine Revenue Market Share by Type (2027-2032) Table 39. Global Betahistine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Betahistine Sales by Type (2021-2026) & (K Units) Table 41. Global Betahistine Sales by Type (2027-2032) & (K Units) Table 42. Global Betahistine Sales Market Share by Type (2021-2026) Table 43. Global Betahistine Sales Market Share by Type (2027-2032) Table 44. Global Betahistine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Betahistine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Betahistine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Betahistine Revenue Market Share by Application (2021-2026) Table 50. Global Betahistine Revenue Market Share by Application (2027-2032) Table 51. Global Betahistine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Betahistine Sales by Application (2021-2026) & (K Units) Table 53. Global Betahistine Sales by Application (2027-2032) & (K Units) Table 54. Global Betahistine Sales Market Share by Application (2021-2026) Table 55. Global Betahistine Sales Market Share by Application (2027-2032) Table 56. Global Betahistine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Betahistine Price by Application (2027-2032) & (US$/Unit) Table 58. TOWA PHARMACEUTICAL CO., LTD Company Information Table 59. TOWA PHARMACEUTICAL CO., LTD Business Overview Table 60. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio Table 62. TOWA PHARMACEUTICAL CO., LTD Recent Development Table 63. Takeda Pharmaceutical Company Limited Company Information Table 64. Takeda Pharmaceutical Company Limited Business Overview Table 65. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Company Limited Betahistine Product Portfolio Table 67. Takeda Pharmaceutical Company Limited Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mylan Betahistine Product Portfolio Table 72. Mylan Recent Development Table 73. Orion Corporation Company Information Table 74. Orion Corporation Business Overview Table 75. Orion Corporation Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Orion Corporation Betahistine Product Portfolio Table 77. Orion Corporation Recent Development Table 78. Nichi-Iko Pharmaceutical Company Information Table 79. Nichi-Iko Pharmaceutical Business Overview Table 80. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Nichi-Iko Pharmaceutical Betahistine Product Portfolio Table 82. Nichi-Iko Pharmaceutical Recent Development Table 83. HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information Table 84. HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview Table 85. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio Table 87. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development Table 88. EA Pharma Co., Ltd. Company Information Table 89. EA Pharma Co., Ltd. Business Overview Table 90. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. EA Pharma Co., Ltd. Betahistine Product Portfolio Table 92. EA Pharma Co., Ltd. Recent Development Table 93. DOC Generici Company Information Table 94. DOC Generici Business Overview Table 95. DOC Generici Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. DOC Generici Betahistine Product Portfolio Table 97. DOC Generici Recent Development Table 98. Disphar International B.V. Company Information Table 99. Disphar International B.V. Business Overview Table 100. Disphar International B.V. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Disphar International B.V. Betahistine Product Portfolio Table 102. Disphar International B.V. Recent Development Table 103. Ciclum Farma Unipessoal Company Information Table 104. Ciclum Farma Unipessoal Business Overview Table 105. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Ciclum Farma Unipessoal Betahistine Product Portfolio Table 107. Ciclum Farma Unipessoal Recent Development Table 108. North America Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Betahistine Sales by Type (2021-2026) & (K Units) Table 111. North America Betahistine Sales by Type (2027-2032) & (K Units) Table 112. North America Betahistine Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America Betahistine Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Betahistine Sales by Application (2021-2026) & (K Units) Table 117. North America Betahistine Sales by Application (2027-2032) & (K Units) Table 118. North America Betahistine Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America Betahistine Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Betahistine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Betahistine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Betahistine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 124. North America Betahistine Sales by Country (2021-2026) & (K Units) Table 125. North America Betahistine Sales by Country (2027-2032) & (K Units) Table 126. North America Betahistine Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America Betahistine Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States Betahistine Revenue (2021-2032) & (US$ Million) Table 129. Canada Betahistine Revenue (2021-2032) & (US$ Million) Table 130. Europe Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Betahistine Sales by Type (2021-2026) & (K Units) Table 133. Europe Betahistine Sales by Type (2027-2032) & (K Units) Table 134. Europe Betahistine Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Betahistine Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Betahistine Sales by Application (2021-2026) & (K Units) Table 139. Europe Betahistine Sales by Application (2027-2032) & (K Units) Table 140. Europe Betahistine Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Betahistine Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Betahistine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Betahistine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Betahistine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Europe Betahistine Sales by Country (2021-2026) & (K Units) Table 147. Europe Betahistine Sales by Country (2027-2032) & (K Units) Table 148. Europe Betahistine Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Betahistine Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Betahistine Revenue (2021-2032) & (US$ Million) Table 151. France Betahistine Revenue (2021-2032) & (US$ Million) Table 152. U.K. Betahistine Revenue (2021-2032) & (US$ Million) Table 153. Italy Betahistine Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Betahistine Revenue (2021-2032) & (US$ Million) Table 155. China Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 156. China Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 157. China Betahistine Sales by Type (2021-2026) & (K Units) Table 158. China Betahistine Sales by Type (2027-2032) & (K Units) Table 159. China Betahistine Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Betahistine Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 162. China Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 163. China Betahistine Sales by Application (2021-2026) & (K Units) Table 164. China Betahistine Sales by Application (2027-2032) & (K Units) Table 165. China Betahistine Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Betahistine Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Betahistine Sales by Type (2021-2026) & (K Units) Table 170. Asia Betahistine Sales by Type (2027-2032) & (K Units) Table 171. Asia Betahistine Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Betahistine Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Betahistine Sales by Application (2021-2026) & (K Units) Table 176. Asia Betahistine Sales by Application (2027-2032) & (K Units) Table 177. Asia Betahistine Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Betahistine Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Betahistine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Betahistine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Betahistine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. Asia Betahistine Sales by Country (2021-2026) & (K Units) Table 184. Asia Betahistine Sales by Country (2027-2032) & (K Units) Table 185. Asia Betahistine Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Betahistine Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Betahistine Revenue (2021-2032) & (US$ Million) Table 188. South Korea Betahistine Revenue (2021-2032) & (US$ Million) Table 189. India Betahistine Revenue (2021-2032) & (US$ Million) Table 190. Australia Betahistine Revenue (2021-2032) & (US$ Million) Table 191. China Taiwan Betahistine Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Betahistine Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Betahistine Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Betahistine Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Betahistine Sales by Type (2021-2026) & (K Units) Table 196. SAMEA Betahistine Sales by Type (2027-2032) & (K Units) Table 197. SAMEA Betahistine Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Betahistine Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Betahistine Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Betahistine Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Betahistine Sales by Application (2021-2026) & (K Units) Table 202. SAMEA Betahistine Sales by Application (2027-2032) & (K Units) Table 203. SAMEA Betahistine Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Betahistine Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Betahistine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Betahistine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Betahistine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. SAMEA Betahistine Sales by Country (2021-2026) & (K Units) Table 210. SAMEA Betahistine Sales by Country (2027-2032) & (K Units) Table 211. SAMEA Betahistine Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Betahistine Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Betahistine Revenue (2021-2032) & (US$ Million) Table 214. Argentina Betahistine Revenue (2021-2032) & (US$ Million) Table 215. Chile Betahistine Revenue (2021-2032) & (US$ Million) Table 216. Colombia Betahistine Revenue (2021-2032) & (US$ Million) Table 217. Peru Betahistine Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Betahistine Revenue (2021-2032) & (US$ Million) Table 219. Israel Betahistine Revenue (2021-2032) & (US$ Million) Table 220. UAE Betahistine Revenue (2021-2032) & (US$ Million) Table 221. Turkey Betahistine Revenue (2021-2032) & (US$ Million) Table 222. Iran Betahistine Revenue (2021-2032) & (US$ Million) Table 223. Egypt Betahistine Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Betahistine Distributors List Table 227. Betahistine Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Betahistine Image Figure 2. Global Betahistine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Betahistine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 8mg Image Figure 5. 25mg Image Figure 6. Others Image Figure 7. Global Betahistine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Betahistine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cerebral Thrombosis Image Figure 10. Cerebral Embolism Image Figure 11. Others Image Figure 12. Global Betahistine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Betahistine Revenue (2021-2032) & (US$ Million) Figure 14. Global Betahistine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Betahistine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Betahistine Revenue Market Share by Region (2021-2032) Figure 17. Global Betahistine Sales (2021-2032) & (K Units) Figure 18. Global Betahistine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Betahistine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Betahistine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Betahistine Sales YoY (2021-2032) & (K Units) Figure 22. China Betahistine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Betahistine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Betahistine Sales YoY (2021-2032) & (K Units) Figure 25. Global Betahistine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Betahistine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Betahistine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Betahistine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Betahistine Revenue Market Share by Type (2021-2032) Figure 31. Global Betahistine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Betahistine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Betahistine Sales Market Share by Type (2021-2032) Figure 34. Global Betahistine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Betahistine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Betahistine Revenue Market Share by Application (2021-2032) Figure 37. Global Betahistine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Betahistine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Betahistine Sales Market Share by Application (2021-2032) Figure 40. North America Betahistine Revenue Share by Type (2021-2032) Figure 41. North America Betahistine Sales Share by Type (2021-2032) Figure 42. North America Betahistine Revenue Share by Application (2021-2032) Figure 43. North America Betahistine Sales Share by Application (2021-2032) Figure 44. North America Betahistine Revenue Share by Country (2021-2032) Figure 45. North America Betahistine Sales Share by Country (2021-2032) Figure 46. Europe Betahistine Revenue Share by Type (2021-2032) Figure 47. Europe Betahistine Sales Share by Type (2021-2032) Figure 48. Europe Betahistine Revenue Share by Application (2021-2032) Figure 49. Europe Betahistine Sales Share by Application (2021-2032) Figure 50. Europe Betahistine Revenue Share by Country (2021-2032) Figure 51. Europe Betahistine Sales Share by Country (2021-2032) Figure 52. China Betahistine Revenue Share by Type (2021-2032) Figure 53. China Betahistine Sales Share by Type (2021-2032) Figure 54. China Betahistine Revenue Share by Application (2021-2032) Figure 55. China Betahistine Sales Share by Application (2021-2032) Figure 56. Asia Betahistine Revenue Share by Type (2021-2032) Figure 57. Asia Betahistine Sales Share by Type (2021-2032) Figure 58. Asia Betahistine Revenue Share by Application (2021-2032) Figure 59. Asia Betahistine Sales Share by Application (2021-2032) Figure 60. Asia Betahistine Revenue Share by Country (2021-2032) Figure 61. Asia Betahistine Sales Share by Country (2021-2032) Figure 62. SAMEA Betahistine Revenue Share by Type (2021-2032) Figure 63. SAMEA Betahistine Sales Share by Type (2021-2032) Figure 64. SAMEA Betahistine Revenue Share by Application (2021-2032) Figure 65. SAMEA Betahistine Sales Share by Application (2021-2032) Figure 66. SAMEA Betahistine Revenue Share by Country (2021-2032) Figure 67. SAMEA Betahistine Sales Share by Country (2021-2032) Figure 68. Betahistine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Betahistine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg
  • 25mg
  • Others
Applications
  • Cerebral Thrombosis
  • Cerebral Embolism
  • Others
Companies covered
  • TOWA PHARMACEUTICAL CO., LTD
  • Takeda Pharmaceutical Company Limited
  • Mylan
  • Orion Corporation
  • Nichi-Iko Pharmaceutical
  • HENNIG ARZNEIMITTEL GmbH & Co. KG
  • EA Pharma Co., Ltd.
  • DOC Generici
  • Disphar International B.V.
  • Ciclum Farma Unipessoal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Betahistine Market by Type
  3. 1.2.1 Global Betahistine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 8mg
  5. 1.2.3 25mg
  6. 1.2.4 Others
  7. 1.3 Betahistine Market by Application
  8. 1.3.1 Global Betahistine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cerebral Thrombosis
  10. 1.3.3 Cerebral Embolism
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Betahistine Market Dynamics
  1. 2.1 Betahistine Industry Trends
  2. 2.2 Betahistine Industry Drivers
  3. 2.3 Betahistine Industry Opportunities and Challenges
  4. 2.4 Betahistine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Betahistine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Betahistine Revenue by Region
  3. 3.2.1 Global Betahistine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Betahistine Revenue by Region (2021-2026)
  5. 3.2.3 Global Betahistine Revenue by Region (2027-2032)
  6. 3.2.4 Global Betahistine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Betahistine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Betahistine Sales by Region
  9. 3.4.1 Global Betahistine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Betahistine Sales by Region (2021-2026)
  11. 3.4.3 Global Betahistine Sales by Region (2027-2032)
  12. 3.4.4 Global Betahistine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Betahistine Revenue by Manufacturers
  2. 4.1.1 Global Betahistine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Betahistine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Betahistine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Betahistine Sales by Manufacturers
  6. 4.2.1 Global Betahistine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Betahistine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Betahistine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Betahistine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Betahistine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Betahistine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Betahistine Manufacturers, Product Type & Application
  13. 4.7 Global Betahistine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Betahistine Market CR5 and HHI
  16. 4.8.2 2025 Betahistine Tier 1, Tier 2, and Tier 3
5 Betahistine Market by Type
  1. 5.1 Global Betahistine Revenue by Type
  2. 5.1.1 Global Betahistine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Betahistine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Betahistine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Betahistine Sales by Type
  6. 5.2.1 Global Betahistine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Betahistine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Betahistine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Betahistine Price by Type
6 Betahistine Market by Application
  1. 6.1 Global Betahistine Revenue by Application
  2. 6.1.1 Global Betahistine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Betahistine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Betahistine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Betahistine Sales by Application
  6. 6.2.1 Global Betahistine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Betahistine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Betahistine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Betahistine Price by Application
7 Company Profiles
  1. 7.1 TOWA PHARMACEUTICAL CO., LTD
  2. 7.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
  3. 7.1.2 TOWA PHARMACEUTICAL CO., LTD Business Overview
  4. 7.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio
  6. 7.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments
  7. 7.2 Takeda Pharmaceutical Company Limited
  8. 7.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 7.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 7.2.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Pharmaceutical Company Limited Betahistine Product Portfolio
  12. 7.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Betahistine Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Orion Corporation
  20. 7.4.1 Orion Corporation Company Information
  21. 7.4.2 Orion Corporation Business Overview
  22. 7.4.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Orion Corporation Betahistine Product Portfolio
  24. 7.4.5 Orion Corporation Recent Developments
  25. 7.5 Nichi-Iko Pharmaceutical
  26. 7.5.1 Nichi-Iko Pharmaceutical Company Information
  27. 7.5.2 Nichi-Iko Pharmaceutical Business Overview
  28. 7.5.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nichi-Iko Pharmaceutical Betahistine Product Portfolio
  30. 7.5.5 Nichi-Iko Pharmaceutical Recent Developments
  31. 7.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
  32. 7.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
  33. 7.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview
  34. 7.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio
  36. 7.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
  37. 7.7 EA Pharma Co., Ltd.
  38. 7.7.1 EA Pharma Co., Ltd. Company Information
  39. 7.7.2 EA Pharma Co., Ltd. Business Overview
  40. 7.7.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 EA Pharma Co., Ltd. Betahistine Product Portfolio
  42. 7.7.5 EA Pharma Co., Ltd. Recent Developments
  43. 7.8 DOC Generici
  44. 7.8.1 DOC Generici Company Information
  45. 7.8.2 DOC Generici Business Overview
  46. 7.8.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 DOC Generici Betahistine Product Portfolio
  48. 7.8.5 DOC Generici Recent Developments
  49. 7.9 Disphar International B.V.
  50. 7.9.1 Disphar International B.V. Company Information
  51. 7.9.2 Disphar International B.V. Business Overview
  52. 7.9.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Disphar International B.V. Betahistine Product Portfolio
  54. 7.9.5 Disphar International B.V. Recent Developments
  55. 7.10 Ciclum Farma Unipessoal
  56. 7.10.1 Ciclum Farma Unipessoal Company Information
  57. 7.10.2 Ciclum Farma Unipessoal Business Overview
  58. 7.10.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ciclum Farma Unipessoal Betahistine Product Portfolio
  60. 7.10.5 Ciclum Farma Unipessoal Recent Developments
8 North America
  1. 8.1 North America Betahistine Market Size by Type
  2. 8.1.1 North America Betahistine Revenue by Type (2021-2032)
  3. 8.1.2 North America Betahistine Sales by Type (2021-2032)
  4. 8.1.3 North America Betahistine Price by Type (2021-2032)
  5. 8.2 North America Betahistine Market Size by Application
  6. 8.2.1 North America Betahistine Revenue by Application (2021-2032)
  7. 8.2.2 North America Betahistine Sales by Application (2021-2032)
  8. 8.2.3 North America Betahistine Price by Application (2021-2032)
  9. 8.3 North America Betahistine Market Size by Country
  10. 8.3.1 North America Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Betahistine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Betahistine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Betahistine Market Size by Type
  2. 9.1.1 Europe Betahistine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Betahistine Sales by Type (2021-2032)
  4. 9.1.3 Europe Betahistine Price by Type (2021-2032)
  5. 9.2 Europe Betahistine Market Size by Application
  6. 9.2.1 Europe Betahistine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Betahistine Sales by Application (2021-2032)
  8. 9.2.3 Europe Betahistine Price by Application (2021-2032)
  9. 9.3 Europe Betahistine Market Size by Country
  10. 9.3.1 Europe Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Betahistine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Betahistine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Betahistine Market Size by Type
  2. 10.1.1 China Betahistine Revenue by Type (2021-2032)
  3. 10.1.2 China Betahistine Sales by Type (2021-2032)
  4. 10.1.3 China Betahistine Price by Type (2021-2032)
  5. 10.2 China Betahistine Market Size by Application
  6. 10.2.1 China Betahistine Revenue by Application (2021-2032)
  7. 10.2.2 China Betahistine Sales by Application (2021-2032)
  8. 10.2.3 China Betahistine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Betahistine Market Size by Type
  2. 11.1.1 Asia Betahistine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Betahistine Sales by Type (2021-2032)
  4. 11.1.3 Asia Betahistine Price by Type (2021-2032)
  5. 11.2 Asia Betahistine Market Size by Application
  6. 11.2.1 Asia Betahistine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Betahistine Sales by Application (2021-2032)
  8. 11.2.3 Asia Betahistine Price by Application (2021-2032)
  9. 11.3 Asia Betahistine Market Size by Country
  10. 11.3.1 Asia Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Betahistine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Betahistine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Betahistine Market Size by Type
  2. 12.1.1 SAMEA Betahistine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Betahistine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Betahistine Price by Type (2021-2032)
  5. 12.2 SAMEA Betahistine Market Size by Application
  6. 12.2.1 SAMEA Betahistine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Betahistine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Betahistine Price by Application (2021-2032)
  9. 12.3 SAMEA Betahistine Market Size by Country
  10. 12.3.1 SAMEA Betahistine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Betahistine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Betahistine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Betahistine Value Chain Analysis
  2. 13.1.1 Betahistine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Betahistine Production Mode & Process
  6. 13.2 Betahistine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Betahistine Distributors
  9. 13.2.3 Betahistine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst